 | • レポートコード：GIR201113486 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、成人及び小児用ワクチンの世界市場を調査対象にし、成人及び小児用ワクチンの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（成人用ワクチン、小児用ワクチン）、用途別分析（病院、医療センター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：GlaxoSmithKline、Takeda Pharmaceutical、Novartis、Sanofi、Johnson and Johnson、Merck、LG Life Sciences、AstraZeneca、Pfizer、Bavarian Nordic、Sinovac Biotech ・企業別売上、市場シェア ・成人及び小児用ワクチンの地域別市場分析 ・成人及び小児用ワクチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・成人及び小児用ワクチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・成人及び小児用ワクチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・成人及び小児用ワクチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・成人及び小児用ワクチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・成人及び小児用ワクチンの種類別市場規模2015-2020：成人用ワクチン、小児用ワクチン ・成人及び小児用ワクチンの用途別市場規模2015-2020：病院、医療センター、その他 ・成人及び小児用ワクチンの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Adult and Pediatric Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Adult and Pediatric Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Adult and Pediatric Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Adult and Pediatric Vaccines market has been segmented into:
Adult Vaccines
Pediatric Vaccines
By Application, Adult and Pediatric Vaccines has been segmented into:
Hospitals
Medical Care Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Adult and Pediatric Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Adult and Pediatric Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Adult and Pediatric Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Adult and Pediatric Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Adult and Pediatric Vaccines Market Share Analysis
Adult and Pediatric Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Adult and Pediatric Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Adult and Pediatric Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Adult and Pediatric Vaccines are:
GlaxoSmithKline
Takeda Pharmaceutical
Novartis
Sanofi
Johnson and Johnson
Merck
LG Life Sciences
AstraZeneca
Pfizer
Bavarian Nordic
Sinovac Biotech
1 Adult and Pediatric Vaccines Market Overview
1.1 Product Overview and Scope of Adult and Pediatric Vaccines
1.2 Classification of Adult and Pediatric Vaccines by Type
1.2.1 Global Adult and Pediatric Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Adult and Pediatric Vaccines Revenue Market Share by Type in 2019
1.2.3 Adult Vaccines
1.2.4 Pediatric Vaccines
1.3 Global Adult and Pediatric Vaccines Market by Application
1.3.1 Overview: Global Adult and Pediatric Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Medical Care Centers
1.3.4 Others
1.4 Global Adult and Pediatric Vaccines Market by Regions
1.4.1 Global Adult and Pediatric Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Adult and Pediatric Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Adult and Pediatric Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Adult and Pediatric Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Adult and Pediatric Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Adult and Pediatric Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Adult and Pediatric Vaccines Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda Pharmaceutical
2.2.1 Takeda Pharmaceutical Details
2.2.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda Pharmaceutical SWOT Analysis
2.2.4 Takeda Pharmaceutical Product and Services
2.2.5 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson and Johnson
2.5.1 Johnson and Johnson Details
2.5.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson and Johnson SWOT Analysis
2.5.4 Johnson and Johnson Product and Services
2.5.5 Johnson and Johnson Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 LG Life Sciences
2.7.1 LG Life Sciences Details
2.7.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 LG Life Sciences SWOT Analysis
2.7.4 LG Life Sciences Product and Services
2.7.5 LG Life Sciences Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bavarian Nordic
2.10.1 Bavarian Nordic Details
2.10.2 Bavarian Nordic Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bavarian Nordic SWOT Analysis
2.10.4 Bavarian Nordic Product and Services
2.10.5 Bavarian Nordic Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sinovac Biotech
2.11.1 Sinovac Biotech Details
2.11.2 Sinovac Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sinovac Biotech SWOT Analysis
2.11.4 Sinovac Biotech Product and Services
2.11.5 Sinovac Biotech Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Adult and Pediatric Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Adult and Pediatric Vaccines Players Market Share
3.2.2 Top 10 Adult and Pediatric Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Adult and Pediatric Vaccines Revenue and Market Share by Regions
4.2 North America Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
5 North America Adult and Pediatric Vaccines Revenue by Countries
5.1 North America Adult and Pediatric Vaccines Revenue by Countries (2015-2020)
5.2 USA Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
6 Europe Adult and Pediatric Vaccines Revenue by Countries
6.1 Europe Adult and Pediatric Vaccines Revenue by Countries (2015-2020)
6.2 Germany Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
6.4 France Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Adult and Pediatric Vaccines Revenue by Countries
7.1 Asia-Pacific Adult and Pediatric Vaccines Revenue by Countries (2015-2020)
7.2 China Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
7.5 India Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
8 South America Adult and Pediatric Vaccines Revenue by Countries
8.1 South America Adult and Pediatric Vaccines Revenue by Countries (2015-2020)
8.2 Brazil Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Adult and Pediatric Vaccines by Countries
9.1 Middle East & Africa Adult and Pediatric Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Adult and Pediatric Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global Adult and Pediatric Vaccines Market Forecast by Type (2019-2024)
10.3 Adult Vaccines Revenue Growth Rate (2015-2025)
10.4 Pediatric Vaccines Revenue Growth Rate (2015-2025)
11 Global Adult and Pediatric Vaccines Market Segment by Application
11.1 Global Adult and Pediatric Vaccines Revenue Market Share by Application (2015-2020)
11.2 Adult and Pediatric Vaccines Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Medical Care Centers Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Adult and Pediatric Vaccines Market Size Forecast (2021-2025)
12.1 Global Adult and Pediatric Vaccines Market Size Forecast (2021-2025)
12.2 Global Adult and Pediatric Vaccines Market Forecast by Regions (2021-2025)
12.3 North America Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
12.6 South America Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Adult and Pediatric Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Adult and Pediatric Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Adult and Pediatric Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Adult and Pediatric Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Adult and Pediatric Vaccines Major Business
Table 7. GlaxoSmithKline Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Adult and Pediatric Vaccines Product and Solutions
Table 10. GlaxoSmithKline Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 12. Takeda Pharmaceutical Adult and Pediatric Vaccines Major Business
Table 13. Takeda Pharmaceutical Adult and Pediatric Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. Takeda Pharmaceutical SWOT Analysis
Table 15. Takeda Pharmaceutical Adult and Pediatric Vaccines Product and Solutions
Table 16. Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Adult and Pediatric Vaccines Major Business
Table 19. Novartis Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Adult and Pediatric Vaccines Product and Solutions
Table 22. Novartis Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sanofi Corporate Information, Location and Competitors
Table 24. Sanofi Adult and Pediatric Vaccines Major Business
Table 25. Sanofi Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 26. Sanofi SWOT Analysis
Table 27. Sanofi Adult and Pediatric Vaccines Product and Solutions
Table 28. Sanofi Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Johnson and Johnson Corporate Information, Location and Competitors
Table 30. Johnson and Johnson Adult and Pediatric Vaccines Major Business
Table 31. Johnson and Johnson Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 32. Johnson and Johnson SWOT Analysis
Table 33. Johnson and Johnson Adult and Pediatric Vaccines Product and Solutions
Table 34. Johnson and Johnson Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Corporate Information, Location and Competitors
Table 36. Merck Adult and Pediatric Vaccines Major Business
Table 37. Merck Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 38. Merck SWOT Analysis
Table 39. Merck Adult and Pediatric Vaccines Product and Solutions
Table 40. Merck Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. LG Life Sciences Corporate Information, Location and Competitors
Table 42. LG Life Sciences Adult and Pediatric Vaccines Major Business
Table 43. LG Life Sciences Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 44. LG Life Sciences SWOT Analysis
Table 45. LG Life Sciences Adult and Pediatric Vaccines Product and Solutions
Table 46. LG Life Sciences Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AstraZeneca Corporate Information, Location and Competitors
Table 48. AstraZeneca Adult and Pediatric Vaccines Major Business
Table 49. AstraZeneca Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 50. AstraZeneca SWOT Analysis
Table 51. AstraZeneca Adult and Pediatric Vaccines Product and Solutions
Table 52. AstraZeneca Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfizer Corporate Information, Location and Competitors
Table 54. Pfizer Adult and Pediatric Vaccines Major Business
Table 55. Pfizer Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 56. Pfizer SWOT Analysis
Table 57. Pfizer Adult and Pediatric Vaccines Product and Solutions
Table 58. Pfizer Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bavarian Nordic Corporate Information, Location and Competitors
Table 60. Bavarian Nordic Adult and Pediatric Vaccines Major Business
Table 61. Bavarian Nordic Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 62. Bavarian Nordic SWOT Analysis
Table 63. Bavarian Nordic Adult and Pediatric Vaccines Product and Solutions
Table 64. Bavarian Nordic Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Sinovac Biotech Corporate Information, Location and Competitors
Table 66. Sinovac Biotech Adult and Pediatric Vaccines Major Business
Table 67. Sinovac Biotech Adult and Pediatric Vaccines Total Revenue (USD Million) (2017-2018)
Table 68. Sinovac Biotech SWOT Analysis
Table 69. Sinovac Biotech Adult and Pediatric Vaccines Product and Solutions
Table 70. Sinovac Biotech Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Adult and Pediatric Vaccines Revenue (Million USD) by Players (2015-2020)
Table 72. Global Adult and Pediatric Vaccines Revenue Share by Players (2015-2020)
Table 73. Global Adult and Pediatric Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Adult and Pediatric Vaccines Revenue Market Share by Regions (2015-2020)
Table 75. North America Adult and Pediatric Vaccines Revenue by Countries (2015-2020)
Table 76. North America Adult and Pediatric Vaccines Revenue Market Share by Countries (2015-2020)
Table 77. Europe Adult and Pediatric Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Adult and Pediatric Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Adult and Pediatric Vaccines Revenue by Countries (2015-2020)
Table 80. South America Adult and Pediatric Vaccines Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Adult and Pediatric Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Adult and Pediatric Vaccines Revenue Market Share by Countries (2015-2020)
Table 83. Global Adult and Pediatric Vaccines Revenue (Million USD) by Type (2015-2020)
Table 84. Global Adult and Pediatric Vaccines Revenue Share by Type (2015-2020)
Table 85. Global Adult and Pediatric Vaccines Revenue Forecast by Type (2021-2025)
Table 86. Global Adult and Pediatric Vaccines Revenue by Application (2015-2020)
Table 87. Global Adult and Pediatric Vaccines Revenue Share by Application (2015-2020)
Table 88. Global Adult and Pediatric Vaccines Revenue Forecast by Application (2021-2025)
Table 89. Global Adult and Pediatric Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Adult and Pediatric Vaccines Picture
Figure 2. Global Adult and Pediatric Vaccines Revenue Market Share by Type in 2019
Figure 3. Adult Vaccines Picture
Figure 4. Pediatric Vaccines Picture
Figure 5. Adult and Pediatric Vaccines Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Medical Care Centers Picture
Figure 8. Others Picture
Figure 9. Global Adult and Pediatric Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Adult and Pediatric Vaccines Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Adult and Pediatric Vaccines Revenue Market Share in 2019
Figure 18. Global Top 10 Players Adult and Pediatric Vaccines Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Adult and Pediatric Vaccines Revenue Market Share by Regions (2015-2020)
Figure 22. Global Adult and Pediatric Vaccines Revenue Market Share by Regions in 2018
Figure 23. North America Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 24. Europe Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 26. South America Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. North America Adult and Pediatric Vaccines Revenue Market Share by Countries (2015-2020)
Figure 29. North America Adult and Pediatric Vaccines Revenue Market Share by Countries in 2019
Figure 30. USA Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 31. Canada Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 33. Europe Adult and Pediatric Vaccines Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Adult and Pediatric Vaccines Revenue Market Share by Countries in 2019
Figure 35. Germany Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 36. UK Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. France Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 38. Russia Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 39. Italy Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Adult and Pediatric Vaccines Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Adult and Pediatric Vaccines Revenue Market Share by Countries in 2019
Figure 42. China Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 43. Japan Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Korea Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 45. India Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. South America Adult and Pediatric Vaccines Revenue Market Share by Countries (2015-2020)
Figure 48. South America Adult and Pediatric Vaccines Revenue Market Share by Countries in 2019
Figure 49. Brazil Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Adult and Pediatric Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Adult and Pediatric Vaccines Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 54. UAE Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Adult and Pediatric Vaccines Revenue and Growth Rate (2015-2020)
Figure 57. Global Adult and Pediatric Vaccines Revenue Share by Type (2015-2020)
Figure 58. Global Adult and Pediatric Vaccines Revenue Share by Type in 2019
Figure 59. Global Adult and Pediatric Vaccines Market Share Forecast by Type (2021-2025)
Figure 60. Global Adult Vaccines Revenue Growth Rate (2015-2020)
Figure 61. Global Pediatric Vaccines Revenue Growth Rate (2015-2020)
Figure 62. Global Adult and Pediatric Vaccines Revenue Share by Application (2015-2020)
Figure 63. Global Adult and Pediatric Vaccines Revenue Share by Application in 2019
Figure 64. Global Adult and Pediatric Vaccines Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Medical Care Centers Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Adult and Pediatric Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Adult and Pediatric Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
Figure 72. Europe Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
Figure 74. South America Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Adult and Pediatric Vaccines Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
小児医療の世界市場 2020年 Market Overview The Pediatric Healthcare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- ワクチンデリバリーの世界市場 2020年 Market Overview The global Vaccines Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vaccines Delivery market re…
- 鳥インフルエンザワクチンの世界市場 2020年 Market Overview The Avian Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 渡航者用ワクチンの世界市場 2020年 Market Overview The Travelers Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 牛ワクチンの世界市場 2020年 Market Overview The global Cattle Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cattle Vaccines market report…